After issuing Form 483, FDA classifies Aurobindo plant as only needing ‘voluntary’ action jkeenan Wed, 12/20/2023 – 09:19 More: After issuing Form 483, FDA classifies Aurobindo plant as only needing 'voluntary' action Source: fierce
read moreNIVI aims to create new or improve vaccines to combat deadly airborne infections More: Novo Nordisk Foundation establishes new vaccine initiative worth 0m Source: News
read moreThe findings could lead to new treatments to target the mTOR and ease PD symptoms More: Key Parkinson’s protein could offer new potential targets for treatment Source: News
read moreAmid BioNTech legal fight, CureVac takes a loss as German court invalidates patent zbecker Tue, 12/19/2023 – 12:32 More: Amid BioNTech legal fight, CureVac takes a loss as German court invalidates patent Source: fierce
read moreRoche, Novartis move Xolair closer to FDA finish line for food allergies kdunleavy Tue, 12/19/2023 – 12:30 More: Roche, Novartis move Xolair closer to FDA finish line for food allergies Source: fierce
read moreFDA rejects Checkpoint’s skin cancer candidate over issue at contract manufacturer kdunleavy Tue, 12/19/2023 – 09:55 More: FDA rejects Checkpoint's skin cancer candidate over issue at contract manufacturer Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals